PUBLISHER: The Insight Partners | PRODUCT CODE: 2165893
PUBLISHER: The Insight Partners | PRODUCT CODE: 2165893
The Europe Continuous Ambulatory Peritoneal Dialysis Market is projected to reach US$ 439.6 Million by 2034, compared with US$ 336.6 Million in 2025. The market is anticipated to register a CAGR of 3.0% from 2026 to 2034.
Executive Summary and Europe Continuous Ambulatory Peritoneal Dialysis Market Analysis:
The continuous ambulatory peritoneal dialysis (CAPD) market in Europe is segmented into the United Kingdom, Germany, France, Italy, Spain, and the Rest of Europe. Market growth is being supported by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), particularly as European populations continue to age and the incidence of diabetes and hypertension rises. These demographic and health trends are increasing the number of patients requiring long-term renal replacement therapy.
CAPD offers several advantages for patients seeking an alternative to conventional in-center hemodialysis. Its home-based nature provides greater flexibility and independence while potentially reducing the need for frequent travel to dialysis facilities. The treatment can therefore contribute to improved patient convenience and quality of life. Its comparatively efficient use of healthcare resources also makes CAPD an attractive option for healthcare systems managing growing dialysis demand.
The increasing preference for home-based renal care is supported by established healthcare infrastructure, reimbursement mechanisms, and government initiatives across several European countries. Technological developments in dialysis solutions, catheters, transfer systems, and supporting equipment are further improving treatment safety, convenience, and reliability.
Greater awareness of CKD and improved access to peritoneal dialysis services are also contributing to market development. CAPD services are increasingly available through hospitals, specialist dialysis centers, and home-care programs, allowing more eligible patients to consider home-based treatment. Together, demographic changes, healthcare-system support, technology improvements, and patient preference are expected to sustain the European CAPD market.
Strategic Insights
Europe Continuous Ambulatory Peritoneal Dialysis Market Segmentation Analysis:
Market Report Scope
Europe Continuous Ambulatory Peritoneal Dialysis Market Outlook
Population aging is becoming an important factor increasing demand for convenient and sustainable renal replacement therapies such as CAPD. According to the World Health Organization, the global population aged 60 years and older is expected to increase from approximately 1.1 billion in 2023 to 1.4 billion by 2030. The continued expansion of the elderly population is particularly relevant to renal care because the risk of CKD and other chronic conditions generally increases with age.
The United Nations has also projected significant growth in the population aged 65 years and above, particularly in developed economies. In addition, the number of people aged 80 years and older is expected to rise substantially over the coming decades. Longer life expectancy, declining birth rates, and improvements in healthcare are contributing to this demographic transition, creating additional pressure on healthcare systems to provide accessible long-term treatment options.
CAPD can be particularly beneficial for older patients because it provides home-based and flexible dialysis without requiring frequent visits to a treatment center. Patients who are able to perform exchanges independently, or who have access to assisted peritoneal dialysis, may incorporate treatment into their daily routines. This flexibility can help preserve independence and reduce some of the logistical challenges associated with facility-based hemodialysis.
Peritoneal dialysis can also be advantageous for certain elderly or medically vulnerable patients who may experience difficulties with vascular access. Unlike hemodialysis, CAPD does not require repeated vascular needle access during treatment sessions. With appropriate clinical supervision and infection-prevention practices, assisted and home-based PD programs can expand treatment options for older individuals.
The broader increase in CKD prevalence further reinforces the need for flexible renal replacement therapies. As more people live longer with chronic conditions and progress to advanced kidney disease, home-centric approaches such as CAPD can help healthcare systems accommodate rising treatment requirements. Its portability, flexibility, and potential for self-management make CAPD an increasingly relevant option for aging populations.
Europe Continuous Ambulatory Peritoneal Dialysis Market Country Insights
By country, the Europe Continuous Ambulatory Peritoneal Dialysis Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. The Rest of Europe held the largest market share in 2025.
Norway, Denmark, Sweden, Poland, Switzerland, the Netherlands, and Belgium are among the countries contributing to market development within the Rest of Europe segment. According to data from the ERA Registry, the prevalence and utilization of kidney replacement therapies differ considerably across European countries. Variations in transplantation rates, healthcare policies, dialysis infrastructure, and the availability of home-based treatment influence the adoption of peritoneal dialysis.
The Nordic countries, including Norway and Denmark, have comparatively high transplantation activity, which can reduce the duration of dependence on dialysis for eligible patients. In contrast, the Netherlands has developed strong home-dialysis programs and demonstrates relatively high utilization of peritoneal dialysis. Poland is also strengthening its kidney disease monitoring and treatment infrastructure as CKD and ESRD requirements increase.
Switzerland and Belgium continue to provide PD as an important home-based treatment option, including assisted approaches for patients requiring additional support. Across these markets, healthcare providers are focusing on infection prevention, individualized dialysis prescriptions, incremental PD approaches, and integration with national healthcare systems.
These country-level differences demonstrate the diversity of the European renal care landscape. Continued improvements in home dialysis services, clinical support, and patient education are expected to help healthcare systems balance treatment modalities while improving outcomes for individuals with kidney failure.
Europe Continuous Ambulatory Peritoneal Dialysis Market Company Profiles
Key companies operating in the market include Terumo Corp, Medtronic Plc, Baxter International Inc, Advin Health Care Pvt Ltd, Fresenius Medical Care AG & Co KGaA, Utah Medical Products Inc, JMS Co Ltd, Polymedicure, Mitra Industries Pvt. Ltd., and Newsol Technologies Inc.
These companies are pursuing strategies such as geographical expansion, product innovation, strategic collaborations, technology development, and mergers and acquisitions. Such initiatives are intended to strengthen product portfolios, improve dialysis technologies, expand distribution networks, and address the growing demand for safe and convenient peritoneal dialysis solutions across Europe.